Green Journals

Year	A	B
2026	✓	✓
2025	✓	✓
2024	✓	✓
2023	✓	✓
2021/2022	✓	✓
2020	✓	✓
2019	✓	✓
2018	✓

Modified CARG Score-Guided First-Line Treatment in Older or Vulnerable Patients With Advanced Non-Small-Cell Lung Cancer: Results of the Randomized, Phase 2 DURATION Trial (AIO-YMO/TRK-0416)

Jonas Kuon, Miriam Blasi, FFarastuk Bozorgmehr et al.

2026-12 Vol. 27 Issue 10 Pages 1-11

DOI: 10.1016/j.cllc.2026.10.004

Stage I Lung Adenocarcinoma in Young Patients (Aged ≤ 50 Years): Beyond Female Nonsmokers

Hina Bhat, Hely Ollila, Amina Tidjani et al.

2026-12 Vol. 27 Issue 10 Pages 12-15

DOI: 10.1016/j.cllc.2026.10.002

Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern Use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

Dasantha Jayamanne, Joseph Chan, Riche Mohan et al.

2026-12 Vol. 27 Issue 10 Pages 16-24

DOI: 10.1016/j.cllc.2026.09.009

Corrigendum to “Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer” [Clinical Lung Cancer 26 (2025) 573-582]

Weibo Cao, Hongtao Duan, Changjian Shao et al.

2026-11 Vol. 27 Issue 9 Pages 51

DOI: 10.1016/j.cllc.2026.09.008

Assessment of Prognostic Value of CEACAM5 Expression Using Archival Tissue and Real-World Evidence of Metastatic Patients with NSCLC in United States

Ashok Krishna, Adam Reich, Gerald Lebovic et al.

2026-11 Vol. 27 Issue 9 Pages 25-33

DOI: 10.1016/j.cllc.2026.09.004

Comparative Effectiveness of First-Line Tyrosine Kinase Inhibitors in ALK-Positive Metastatic Non–Small Cell Lung Cancer by Presence of Brain Metastases

Sharmistha Ghosh, Yuanbin Chen, Hoa H. Le et al.

2026-11 Vol. 27 Issue 9 Pages 11-19

DOI: 10.1016/j.cllc.2026.08.009

Low Baseline Absolute Neutrophil Count and Chemotherapy Safety in African American Patients with Advanced Lung Cancer: A Retrospective Cohort Study

Mumtu Lalla, Simo Du, Rajvi Gor et al.

2026-11 Vol. 27 Issue 9 Pages 20-24

DOI: 10.1016/j.cllc.2026.08.013

Durable Response After Pembrolizumab for Recurrent Tracheal Squamous Cell Carcinoma: A Case Report and Focused Literature Review

Sreoshy Saha, Jongyeob Kim, Inae Park et al.

2026-11 Vol. 27 Issue 9 Pages 34-38

DOI: 10.1016/j.cllc.2026.09.005

Racial Disparities in Thymic Epithelial Tumors: Insights From a Multiracial Urban Cohort

Erica Pietroluongo, Christine M. Bestvina, Anna Di Lello et al.

2026-11 Vol. 27 Issue 9 Pages 44-50

DOI: 10.1016/j.cllc.2026.09.006

The Impact of Tumor Immune Microenvironment in EGFR-Mutant Non-Small Cell Lung Cancer on the Efficacy of Osimertinib

Megumi Mizutani, Yoshiya Matsumoto, Chisato Ohe et al.

2026-11 Vol. 27 Issue 9 Pages 1-10

DOI: 10.1016/j.cllc.2026.09.003

Journal Report

Journal Information

Classification History

Recent Articles